DRSIGNAL BIOTECHNOLOGY CO., LTD.
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
Their core 3A-GTP system uses AI, AR, and automation to greatly increase cell production efficiency, reduce costs, and collect extensive data for deep learning, while also supporting sustainable practices like green CO₂ cell processing.
The content above was translated by Ai
Founded Year
2013
Unified Business No.
54291981
Status
Active
Number of Employees
0
Total Paid-in
Capital
278,750,000 (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
DrSignal BioTechnology, founded in 2013 in Taipei, Taiwan, specializes in automated cell production lines and CDMO services, integrating AI, automation, and biomedicine to standardize and optimize cell manufacturing.
The content above was translated by Ai
